Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Immunity & Ageing

Fig. 3

From: Effects of autologous serum on TREM2 and APOE in a personalized monocyte-derived macrophage assay of late-onset Alzheimer’s patients

Fig. 3

APOE synthesis in short- and long-term differentiated Mo-MФs and serum effects. APOE secretion levels in Mo-MФs cultures from AD patients (n = 21) and CO (n = 16) a in FCS or b in AS. c Effects of AS vs. FCS on APOE secretion levels in short-term and long-term Mo-MФs from AD patients (n = 21) and CO (n = 16). Dots represent individual participant values. a, b Closed bars and symbols represent M0 (light grey for short-term; dark grey for long-term), M1 (light blue for short-term; dark blue for long-term) and M2 (light orange for short-term; dark orange for long-term) macrophages respectively. c Closed violins and symbols represent AS (green) and FCS (dark grey). mRNA (normalized to GAPDH) expression was measured with RT-qPCR. The Friedman ANOVA test or Wilcoxon signed rank test (paired) was used to compare within-group differences. Significant values of ANOVA tests were then subjected to Dunn's multiple comparison test with Bonferroni correction. Statistical significance was determined at the p ≤ 0.05 level unless a Bonferroni adjustment was required for multiple comparisons) p* < 0.0167 (p/n, assuming n = 3 comparison)

Back to article page